Product Information
DIAZEPAM 5 MG/5 ML SOLUTION is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1071 per ML under NDC 00054318863. Its NADAC has been published 528 times since Nov 28, 2013.
FDA first approved this application on Apr 3, 1987. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054318863
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA070928FDA Approved
4/3/1987
TE Code
AA
On Market Since
4/3/1987
Pharmacological Classes
Price Statistics
The NADAC for DIAZEPAM 5 MG/5 ML SOLUTION has been published 528 times since Nov 28, 2013, and over the history we have for it it has risen 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1071 per ML |
|---|---|
| All-time high | $0.1218 (Jul 13, 2016) |
| All-time low | $0.0905 (Feb 19, 2014) |
| 52-week high | $0.1100 |
| 52-week low | $0.1071 |
| Median price | $0.1072 |
| Average price | $0.1069 |
| Largest weekly change | +12.9% (Mar 19, 2014) |
| Weeks tracked | 528 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZEPAM 5 MG/5 ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 5 MG/5 ML SOLUTION, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1071 per ML (NDC 00054318863), effective Sep 30, 2026.
How has the price of DIAZEPAM 5 MG/5 ML SOLUTION changed over time?
Over the history we have for it, the NADAC for DIAZEPAM 5 MG/5 ML SOLUTION has risen 17.2%. It has been tracked across 528 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIAZEPAM 5 MG/5 ML SOLUTION?
Since Nov 28, 2013, the NADAC for DIAZEPAM 5 MG/5 ML SOLUTION has ranged from a low of $0.0905 (Feb 19, 2014) to a high of $0.1218 (Jul 13, 2016), with a median of $0.1072 per ML.
Are there cheaper alternatives to DIAZEPAM 5 MG/5 ML SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 5 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZEPAM 5 MG/5 ML SOLUTION?
DIAZEPAM 5 MG/5 ML SOLUTION (NDC 00054318863) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.